eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0014859|esophageal cancer |
| Sentences | 4 |
| PubMedID- 23739864 | Yoneda, et al.22 (2007) reported that a professional oral care regimen in patients with esophageal cancer enabled the total population of oral streptococci microflora to remain stable and inhibited infections of the oral cavity by opportunistic pathogens, thereby inhibiting oral mucositis. |
| PubMedID- 20429725 | Background: ecf (epirubicin, cisplatin, 5-fu) has been a standard first-line regimen in patients with advanced gastro-esophageal cancer (gec). |
| PubMedID- 25691281 | Background: we performed a prospective, multi-institutional, phase-ii, clinical trial of a docetaxel, nedaplatin, and 5-fluorouracil (dnf) regimen in patients with unresectable esophageal cancer. |
| PubMedID- 24742740 | Background: the combination of stent insertion and single high-dose brachytherapy is a feasible and safe palliative treatment regimen in patients with unresectable oesophageal cancer. |
Page: 1